Indiclinica   Report issue

For profit Phase 2
Founded: Wayne PA United States (2016)

Organization Overview

First Clinical Trial
2016
NCT02709031
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

Cicletanine (1 trial)

magnesium oxide (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Hypertension (Phase 2)

Hypokalemia (Phase 2)

Hyponatremia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2